Hofseth BioCare Balance Sheet Health
Financial Health criteria checks 1/6
Hofseth BioCare has a total shareholder equity of NOK103.1M and total debt of NOK195.6M, which brings its debt-to-equity ratio to 189.8%. Its total assets and total liabilities are NOK365.3M and NOK262.2M respectively.
Key information
189.8%
Debt to equity ratio
NOK 195.58m
Debt
| Interest coverage ratio | n/a |
| Cash | NOK 23.38m |
| Equity | NOK 103.07m |
| Total liabilities | NOK 262.24m |
| Total assets | NOK 365.31m |
Recent financial health updates
Hofseth BioCare (OB:HBC) Is Carrying A Fair Bit Of Debt
Dec 17
Here's Why Hofseth BioCare (OB:HBC) Can Afford Some Debt
Apr 01We Think Hofseth BioCare (OB:HBC) Has A Fair Chunk Of Debt
Dec 22Health Check: How Prudently Does Hofseth BioCare (OB:HBC) Use Debt?
Apr 28Hofseth BioCare (OB:HBC) Is Carrying A Fair Bit Of Debt
Oct 16Is Hofseth BioCare (OB:HBC) Using Debt Sensibly?
Feb 24Recent updates
Hofseth BioCare ASA's (OB:HBC) Shares Leap 36% Yet They're Still Not Telling The Full Story
Dec 18Hofseth BioCare (OB:HBC) Is Carrying A Fair Bit Of Debt
Dec 17Here's Why Hofseth BioCare (OB:HBC) Can Afford Some Debt
Apr 01We Think Hofseth BioCare (OB:HBC) Has A Fair Chunk Of Debt
Dec 22Health Check: How Prudently Does Hofseth BioCare (OB:HBC) Use Debt?
Apr 28Hofseth BioCare (OB:HBC) Is Carrying A Fair Bit Of Debt
Oct 16Is Hofseth BioCare (OB:HBC) Using Debt Sensibly?
Feb 24How Much Of Hofseth BioCare ASA (OB:HBC) Do Insiders Own?
Jan 28Are Insiders Buying Hofseth BioCare ASA (OB:HBC) Stock?
Dec 25
Hofseth BioCare (OB:HBC) Shareholders Have Enjoyed A Whopping 339% Share Price Gain
Nov 20Financial Position Analysis
Short Term Liabilities: HBC's short term assets (NOK125.3M) do not cover its short term liabilities (NOK172.5M).
Long Term Liabilities: HBC's short term assets (NOK125.3M) exceed its long term liabilities (NOK89.7M).
Debt to Equity History and Analysis
Debt Level: HBC's net debt to equity ratio (167.1%) is considered high.
Reducing Debt: HBC's debt to equity ratio has increased from 95.3% to 189.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HBC has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: HBC has less than a year of cash runway if free cash flow continues to grow at historical rates of 7.5% each year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 09:06 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hofseth BioCare ASA is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jonas Peciulis | Norne Securities AS |
| Henning Steffenrud | Swedbank Norway |